Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk (EPICODE)

January 8, 2021 updated by: Eun Soo Kim, MD, PhD, Kyungpook National University Hospital

Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea

The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Daegu, Korea, Republic of, 700-712
        • Recruiting
        • Keimyung University Dongsan Medical Center
        • Principal Investigator:
          • Eun Soo Kim, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients with inflammatory bowel disease from primary, secondary, and tertiary hospital in Daegu-Gyeongbuk province of Korea.

Description

Inclusion Criteria:

  • Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
  • Followed up for at least 6 months for the correct diagnosis

Exclusion Criteria:

  • Patients who do not live in Daegu-Gyeongbuk province

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
inflammatory bowel disease

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All newly diagnosed cases
Time Frame: one year
In one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All operation cases
Time Frame: one year
For one year, all patients who have surgical managements for IBD are counted.
one year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cases of disease relapse
Time Frame: one year
For one year, all patients who have disease worsening are counted.
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2014

Primary Completion (ANTICIPATED)

December 1, 2025

Study Completion (ANTICIPATED)

December 1, 2026

Study Registration Dates

First Submitted

July 16, 2014

First Submitted That Met QC Criteria

July 16, 2014

First Posted (ESTIMATE)

July 17, 2014

Study Record Updates

Last Update Posted (ACTUAL)

January 12, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

January 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Chronic Inflammatory Bowel Disease

3
Subscribe